Pharmaceuticals Portfolio Pharmaceuticals Fund Market Value
FPHAX Fund | USD 24.34 0.27 1.12% |
Symbol | Pharmaceuticals |
Pharmaceuticals Portfolio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmaceuticals Portfolio's mutual fund what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmaceuticals Portfolio.
05/07/2025 |
| 08/05/2025 |
If you would invest 0.00 in Pharmaceuticals Portfolio on May 7, 2025 and sell it all today you would earn a total of 0.00 from holding Pharmaceuticals Portfolio Pharmaceuticals or generate 0.0% return on investment in Pharmaceuticals Portfolio over 90 days. Pharmaceuticals Portfolio is related to or competes with Transportation Portfolio, Multimedia Portfolio, Health Care, Industrials Portfolio, and Consumer Discretionary. The fund normally invests at least 80 percent of assets in companies engaged in the research, development, manufacture, ... More
Pharmaceuticals Portfolio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmaceuticals Portfolio's mutual fund current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmaceuticals Portfolio Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
Information Ratio | (0.08) | |||
Maximum Drawdown | 7.78 | |||
Value At Risk | (2.74) | |||
Potential Upside | 2.68 |
Pharmaceuticals Portfolio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmaceuticals Portfolio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmaceuticals Portfolio's standard deviation. In reality, there are many statistical measures that can use Pharmaceuticals Portfolio historical prices to predict the future Pharmaceuticals Portfolio's volatility.Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0) | |||
Total Risk Alpha | (0.25) | |||
Treynor Ratio | 0.1243 |
Pharmaceuticals Portfolio Backtested Returns
At this stage we consider Pharmaceuticals Mutual Fund to be very steady. Pharmaceuticals Portfolio maintains Sharpe Ratio (i.e., Efficiency) of 0.0551, which implies the entity had a 0.0551 % return per unit of risk over the last 3 months. We have found twenty-one technical indicators for Pharmaceuticals Portfolio, which you can use to evaluate the volatility of the fund. Please check Pharmaceuticals Portfolio's insignificant Risk Adjusted Performance, coefficient of variation of (8,644), and Variance of 2.73 to confirm if the risk estimate we provide is consistent with the expected return of 0.0798%. The fund holds a Beta of -0.23, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Pharmaceuticals Portfolio are expected to decrease at a much lower rate. During the bear market, Pharmaceuticals Portfolio is likely to outperform the market.
Auto-correlation | 0.18 |
Very weak predictability
Pharmaceuticals Portfolio Pharmaceuticals has very weak predictability. Overlapping area represents the amount of predictability between Pharmaceuticals Portfolio time series from 7th of May 2025 to 21st of June 2025 and 21st of June 2025 to 5th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmaceuticals Portfolio price movement. The serial correlation of 0.18 indicates that over 18.0% of current Pharmaceuticals Portfolio price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.18 | |
Spearman Rank Test | 0.04 | |
Residual Average | 0.0 | |
Price Variance | 0.29 |
Pharmaceuticals Portfolio lagged returns against current returns
Autocorrelation, which is Pharmaceuticals Portfolio mutual fund's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Pharmaceuticals Portfolio's mutual fund expected returns. We can calculate the autocorrelation of Pharmaceuticals Portfolio returns to help us make a trade decision. For example, suppose you find that Pharmaceuticals Portfolio has exhibited high autocorrelation historically, and you observe that the mutual fund is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Pharmaceuticals Portfolio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Pharmaceuticals Portfolio mutual fund is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Pharmaceuticals Portfolio mutual fund is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Pharmaceuticals Portfolio mutual fund over time.
Current vs Lagged Prices |
Timeline |
Pharmaceuticals Portfolio Lagged Returns
When evaluating Pharmaceuticals Portfolio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Pharmaceuticals Portfolio mutual fund have on its future price. Pharmaceuticals Portfolio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Pharmaceuticals Portfolio autocorrelation shows the relationship between Pharmaceuticals Portfolio mutual fund current value and its past values and can show if there is a momentum factor associated with investing in Pharmaceuticals Portfolio Pharmaceuticals.
Regressed Prices |
Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Portfolio financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Portfolio security.
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |